Itai Levi

2.2k citations
70 papers · 1.7k · 1 hit paper · h-index 18

Impact in

    • Lymphoma Diagnosis and Treatment
  • Hematology top 2%
    • Iron Metabolism and Disorders
    • Acute Myeloid Leukemia Research
    • Platelet Disorders and Treatments
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments

Papers in

Itai Levi

68 papers receiving 1.6k citations

Itai Levi's Hit Papers

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial 2018 · 561 citations
5610+2+5Years since publication100200300400500

Peers

Itai Levi
Comparison fields: 5 of 70
  • Pathology and Forensic Medicine 613
  • Hematology 408
  • Genetics 94
  • Family Practice 17
  • Oncology 122
Replace Joon Ho Moon with:
Joon Ho Moon South Korea
Jae‐Yong Kwak South Korea
Ronit Gurion Israel
Carlyn Rose C. Tan United States
Ho‐Young Yhim South Korea
Johanna W. Baars Netherlands
Patrizia Pregno Italy
James H. Essell United States
Pascal Lenain France
Won Sik Lee South Korea
Itai Levi relative to Joon Ho Moon South Korea Joon Ho Moon's profile →
Citations per field
00.5×1.5×
Joon Ho Moon · 1×
Citations per year

Countries citing papers authored by Itai Levi

Since Specialization
Citations

This map shows the geographic impact of Itai Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itai Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itai Levi more than expected).

Fields of papers citing papers by Itai Levi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itai Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itai Levi. The network helps show where Itai Levi may publish in the future.

Co-authors

The 25 scholars most cited alongside Itai Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Itai Levi Line = papers co-authored together Itai Levi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Hit paper breakdown →
2018561
2 2008117
3 2006107
4 201287
5 201161
6 200153
7 202050
8 200444
9 201235
10 200734
11 202232
12 200030
13 202128
14 202026
15 200425
16 201221
17 201120
18 201119
19 199917
20 200517

About Itai Levi

Itai Levi is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Toxicology and Family Practice, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Platelet Disorders and Treatments (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Medication Adherence and Compliance (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (613 citations), Hematology (408 citations), Genetics (94 citations), Family Practice (17 citations) and Oncology (122 citations). Itai Levi has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Ofer Shpilberg, Isaac Ben‐Bassat, Ronit Yerushalmi, Hanna Shalev, Hannah Tamary, Galit Perez‐Avraham, Daniel Benharroch, Arnon Nagler, Dorine W. Swinkels and Abraham Avigdor. Their work appears in journals such as Blood, Hematological Oncology, European Journal Of Haematology, Annals of Hematology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact